JP2001039976A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001039976A5 JP2001039976A5 JP2000151138A JP2000151138A JP2001039976A5 JP 2001039976 A5 JP2001039976 A5 JP 2001039976A5 JP 2000151138 A JP2000151138 A JP 2000151138A JP 2000151138 A JP2000151138 A JP 2000151138A JP 2001039976 A5 JP2001039976 A5 JP 2001039976A5
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- active ingredient
- preventing
- agent
- prophylactic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 150000001875 compounds Chemical class 0.000 description 11
- 239000004480 active ingredient Substances 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000000069 prophylactic effect Effects 0.000 description 3
- 229940126585 therapeutic drug Drugs 0.000 description 3
- 208000002249 Diabetes Complications Diseases 0.000 description 2
- 206010012655 Diabetic complications Diseases 0.000 description 2
- 206010022489 Insulin Resistance Diseases 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 229940043274 prophylactic drug Drugs 0.000 description 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 2
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- 208000002705 Glucose Intolerance Diseases 0.000 description 1
- 229940122355 Insulin sensitizer Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 201000009104 prediabetes syndrome Diseases 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- XMSXOLDPMGMWTH-UHFFFAOYSA-N rivoglitazone Chemical compound CN1C2=CC(OC)=CC=C2N=C1COC(C=C1)=CC=C1CC1SC(=O)NC1=O XMSXOLDPMGMWTH-UHFFFAOYSA-N 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000151138A JP2001039976A (ja) | 1999-05-24 | 2000-05-23 | 縮合複素環化合物の塩酸塩 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11-143513 | 1999-05-24 | ||
| JP14351399 | 1999-05-24 | ||
| JP2000151138A JP2001039976A (ja) | 1999-05-24 | 2000-05-23 | 縮合複素環化合物の塩酸塩 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001039976A JP2001039976A (ja) | 2001-02-13 |
| JP2001039976A5 true JP2001039976A5 (no) | 2007-07-12 |
Family
ID=26475217
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000151138A Ceased JP2001039976A (ja) | 1999-05-24 | 2000-05-23 | 縮合複素環化合物の塩酸塩 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2001039976A (no) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1679074T3 (da) * | 2003-10-24 | 2011-03-21 | Santen Pharmaceutical Co Ltd | Terapeutisk middel til keratoconjunktive forstyrrelser |
| KR20060118520A (ko) | 2003-10-29 | 2006-11-23 | 산텐 세이야꾸 가부시키가이샤 | 각결막장해 치료제 |
| JP2006225382A (ja) * | 2005-01-24 | 2006-08-31 | Sankyo Co Ltd | チアゾリジンジオン化合物の製造方法及びその製造中間体 |
| TW200637856A (en) | 2005-01-24 | 2006-11-01 | Sankyo Co | Process for producing thiazolidinedion compound and intermediate thereof |
| CN101336113B (zh) | 2005-11-28 | 2015-07-29 | 千寿制药株式会社 | 包括ppar激动剂的药物 |
| JP2008044932A (ja) * | 2006-07-21 | 2008-02-28 | Daiichi Sankyo Co Ltd | チアゾリジンジオン化合物を含有する組成物 |
| TW200816995A (en) * | 2006-08-31 | 2008-04-16 | Daiichi Sankyo Co Ltd | Pharmaceutical composition containing insulin sensitizers |
| KR101508020B1 (ko) | 2007-05-21 | 2015-04-06 | 센주 세이야꾸 가부시키가이샤 | Ｐｐａｒδ 아고니스트 함유 의약 |
-
2000
- 2000-05-23 JP JP2000151138A patent/JP2001039976A/ja not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2001131722A (ru) | 5-[4-(6-Метокси-1-метил-1Н-бензимидазол-2-илметокси)бензил]-тиазолидин-2,4 -ди он гидрохлорид, обладающий гипогликемической активностью | |
| JP2003501361A5 (no) | ||
| AU2002244860A1 (en) | Treatment of type 2 diabetes with inhibitors of dipeptidyl peptidase IV | |
| CZ20032927A3 (cs) | Léčení cukrovky typu 2 inhibitory z dipeptidylpeptidázy IV | |
| JP2007533722A5 (no) | ||
| TWI255817B (en) | Glucopyranosyloxybenzylbenzene derivatives and medicinal use thereof | |
| EP1803721A4 (en) | INNOVATIVE GLUCITOL DERIVATIVE, PRECURSOR OF THE MEDICINAL PRODUCT AND SALT THEREOF, AND A THERAPEUTIC AGENT FOR DIABETES CONTAINING THE SAME | |
| JP2010530431A5 (no) | ||
| JP2006502187A5 (no) | ||
| JP2007533733A5 (no) | ||
| JP2007519649A5 (no) | ||
| EP1806347A4 (en) | PYRIMIDINE DERIVATIVES FUSED WITH AN AROMATIC RING | |
| JP2004522714A5 (no) | ||
| MXPA03006217A (es) | Sistema de administracion espaciada de farmacos. | |
| WO2009127974A3 (ko) | 심혈관계 질환 치료용 약제학적 제제 | |
| JP2005526696A5 (no) | ||
| JP2001039976A5 (no) | ||
| EP1612208A3 (en) | N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation | |
| JP2002508372A5 (no) | ||
| US20160287549A1 (en) | Novel methods for treating neurodegenerative diseases | |
| JP2007538102A5 (no) | ||
| WO2005039578A3 (en) | Use of a deoxynojirimycin derivative or a pharmaceutically salt thereof | |
| WO2007007757A1 (ja) | PPARγアゴニストを含有する医薬組成物 | |
| BR112019026029A2 (pt) | Formulações farmacêuticas orais de remogliflozina | |
| JP2002532416A5 (ja) | 脳のグルコース利用を増進させる医薬組成物 |